Stay updated on Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page.

Latest updates to the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page
- CheckyesterdayChange DetectedNew history entries show that study results have been posted and new results-related sections (Outcome Measures (Results)) and the Limitations and Caveats have been added, along with an updated Study Status. The previous entry 'Results Submitted' has been removed in favor of these current, results-focused updates.SummaryDifference0.5%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision v3.7.0 was added to the study record history, and the previous revision v3.6.6 was removed from the list.SummaryDifference0.1%

- Check29 days agoChange DetectedThe history page now displays Revision: v3.6.6 instead of Revision: v3.6.5, reflecting a small software update.SummaryDifference0.1%

- Check50 days agoChange DetectedA newer revision label v3.6.5 appears in the history, replacing the previous revision v3.6.4. This indicates a page version update rather than changes to the study data or descriptions.SummaryDifference0.1%

- Check57 days agoChange DetectedVersion 28 was submitted on 2026-07-06, updating the study record with changes to key sections such as Adverse Events, Baseline Characteristics, Outcome Measures, and Study Status. A subsequent 2026-07-29 entry indicates the record was Returned with a Quality Control Review Has Not Concluded, highlighting ongoing QC on the latest data.SummaryDifference0.6%

- Check64 days agoChange DetectedThe study history page now shows a new site revision, v3.6.4, in place of the previous v3.6.3. This appears to be a front-end update to the page and does not modify the trial's records or content.SummaryDifference0.1%

Stay in the know with updates to Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page.